Bronchopulmonary carcinoid in multiple endocrine neop... [Cancer. 2005] - PubMed - NCBI

Bronchopulmonary carcinoid in multiple endocrine neop... [Cancer. 2005] - PubMed - NCBI

Non-small cell lung cancer staging -National Cancer Institute

Stage Information for NSCLC -National Cancer Institute

Background
Staging Evaluation
Evaluation of mediastinal lymph node metastasis
Evaluation of brain metastasis
Evaluation of distant metastasis other than the brain
The Revised International System for Staging Lung Cancer
AJCC Stage Groupings and TNM Definitions

Non-small cell lung cancer (NSCLC) -general information

Non-Small Cell Lung Cancer -National Cancer Institute

Incidence and Mortality
Anatomy
Pathogenesis
Pathology
Risk Factors
Prevention
Screening
Clinical Features
Diagnosis
Molecular Features
Prognostic Factors
Related Summaries

Carcinoid lung tumors – incidence, treatment and outcomes: a population-based study

Carcinoid lung tumors – incidence, treatment and outcomes: a population-based study
Anne Naalsund, Hans Rostad, Erik Heyerdahl Strøm, May Brit Lund, and Trond-Eirik Strand
Eur J Cardiothorac Surg (2011) 39 (4): 565-569 doi:10.1016/j.ejcts.2010.08.036

Learning about Carcinoid Syndrome

CarcinoidLink

Educational resources offered by Novartis Oncology.  If you're new to the issue of carcinoid tumors or carcinoid syndrome I suggest viewing the videos.

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial : The Lancet Oncology

CRISPR/Cas technique allows precise modification of genome

Exclusive: 'Jaw-dropping' breakthrough hailed as landmark in fight against hereditary diseases as Crispr technique heralds genetic revolution - Science - News - The Independent

• David Adams, a DNA scientist at the Wellcome Trust Sanger Institute in Cambridge, said that the technique has the potential to transform the way scientists are able to manipulate the genes of all living organisms, especially patients with inherited diseases, cancer or lifelong HIV infection.
  
  “This is the first time we’ve been able to edit the genome efficiently and precisely and at a scale that means individual patient mutations can be corrected,” Dr Adams said.